Clinical programs operated by the Section include one of Canada’s largest blood and marrow transplant programs for both allogeneic and autologous hematopoietic stem cell transplantation directed by Dr. Andrew Daly.
Greater than 200 adult patients receive hematopoietic stem cell transplants in Calgary each year. Medical staff for the Bone Marrow Transplant Program includes 9 Hematologists/Oncologists, 3 clinical associates/ward physicians, as well as dedicated nurses, pharmacists, psychologists and social workers.
The Hematology Tumor Group at the TBCC treats greater than 500 newly diagnosed patients annually, and has a very active Clinical Research Program including multicentre cooperative oncology group studies, industry sponsored clinical trials, local investigator-initiated studies, as well as translational research projects.
In addition to Hematologists, membership of the Hematology Tumor Group include an advanced practice nurse, clinical research coordinators, and clinical research nurses, as well as numerous clinic nurses, 7 hematopathologists, 2 radiation and 1 medical oncologists. Within Benign Hematology, Dr. Deepa Suryanarayan chairs the Calgary Thrombosis interest group, composed of representatives from Emergency departments, radiology, pulmonary medicine, and other specialties, whose goal is to improve the prevention and management of venous thromboembolism in the Calgary zone. Dr. Man-Chiu Poon, an internationally recognized researcher in the area of hemophilia, is the leader of the Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program. Dr. Jennifer Grossman has established an adult immune deficiencies program to investigate and manage patients with known or suspected immune deficiencies.
The Division of Hematology and Hematological malignancies provides patient care in Calgary’s four major hospitals, the Tom Baker cancer center, as well as at the Medicine Hat Cancer center.